1. Home
  2. ULY vs RNAZ Comparison

ULY vs RNAZ Comparison

Compare ULY & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • RNAZ
  • Stock Information
  • Founded
  • ULY 2013
  • RNAZ 2016
  • Country
  • ULY United States
  • RNAZ United States
  • Employees
  • ULY N/A
  • RNAZ N/A
  • Industry
  • ULY
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • RNAZ Health Care
  • Exchange
  • ULY Nasdaq
  • RNAZ Nasdaq
  • Market Cap
  • ULY 6.3M
  • RNAZ 6.1M
  • IPO Year
  • ULY N/A
  • RNAZ 2021
  • Fundamental
  • Price
  • ULY $3.76
  • RNAZ $11.15
  • Analyst Decision
  • ULY Strong Buy
  • RNAZ Strong Buy
  • Analyst Count
  • ULY 2
  • RNAZ 1
  • Target Price
  • ULY $11.50
  • RNAZ $280.00
  • AVG Volume (30 Days)
  • ULY 74.4K
  • RNAZ 13.3K
  • Earning Date
  • ULY 08-12-2025
  • RNAZ 08-14-2025
  • Dividend Yield
  • ULY N/A
  • RNAZ N/A
  • EPS Growth
  • ULY N/A
  • RNAZ N/A
  • EPS
  • ULY N/A
  • RNAZ N/A
  • Revenue
  • ULY $131,235,000.00
  • RNAZ N/A
  • Revenue This Year
  • ULY N/A
  • RNAZ N/A
  • Revenue Next Year
  • ULY $20.23
  • RNAZ N/A
  • P/E Ratio
  • ULY N/A
  • RNAZ N/A
  • Revenue Growth
  • ULY N/A
  • RNAZ N/A
  • 52 Week Low
  • ULY $2.99
  • RNAZ $6.15
  • 52 Week High
  • ULY $17.99
  • RNAZ $739.20
  • Technical
  • Relative Strength Index (RSI)
  • ULY 31.35
  • RNAZ 57.11
  • Support Level
  • ULY $3.75
  • RNAZ $10.00
  • Resistance Level
  • ULY $4.70
  • RNAZ $10.48
  • Average True Range (ATR)
  • ULY 0.37
  • RNAZ 0.62
  • MACD
  • ULY -0.02
  • RNAZ 0.08
  • Stochastic Oscillator
  • ULY 5.06
  • RNAZ 86.11

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: